Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C-type natriuretic peptide and heart failure.

Silvia Del Ry1, Claudio Passino, Michele Emdin

  • 1CNR Institute of Clinical Physiology, National Research Council Via Giuseppe Moruzzi 1, 56124 Pisa, Italy.

Pharmacological Research
|August 15, 2006
PubMed
Summary

C-type natriuretic peptide (CNP), a vasodilator, is increasingly recognized for its role in cardiovascular functions. Research suggests CNP may be a significant mediator in heart failure, though further study is needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping global inequities in telemedicine implementation: An umbrella review of barriers and facilitators.

PloS one·2026
Same author

Prognostic impact of chronotropic incompetence in transthyretin cardiac amyloidosis: a multicentre study.

ESC heart failure·2026
Same author

Beyond the slope: prognostic utility of the VE/VCO<sub>2</sub> intercept in chronic heart failure.

Open heart·2026
Same author

Atrial fibrillation secondary to diffuse large B-cell lymphoma responding to corticosteroid treatment: a case report.

European heart journal. Case reports·2026
Same author

Obstructive Sleep Apneas and Cardiovascular Diseases.

Clocks & sleep·2026
Same author

Functional Assessment of Hypertrophic Phenotype Cardiomyopathies Using Combined Cardiopulmonary Exercise Testing and Echocardiography: A Pilot Single-Centre Study.

Journal of clinical medicine·2026

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Molecular Biology

Background:

  • C-type natriuretic peptide (CNP) is a vasodilator produced by vascular endothelium.
  • CNP shares properties with atrial (ANP) and brain natriuretic peptides (BNP), key in heart failure.
  • The precise role of CNP in cardiovascular pathophysiology, especially heart failure, remains under investigation.

Purpose of the Study:

  • To review the cardiovascular functions of CNP.
  • To examine the specific role of CNP in the pathophysiology of chronic heart failure (CHF).

Main Methods:

  • Literature review of existing studies on CNP.
  • Analysis of CNP's genetic regulation and peptide forms.
  • Investigation of CNP's presence and levels in myocardial tissue and plasma.

Related Experiment Videos

Main Results:

  • CNP is produced in the myocardium, with elevated plasma levels observed in CHF.
  • Two mature forms, CNP-53 (tissue) and CNP-22 (plasma), have been identified.
  • Gene transcription is influenced by factors like tumor necrosis factor and interleukin-1.

Conclusions:

  • CNP exhibits vasodilative properties and is implicated in cardiovascular regulation.
  • CNP may function as a crucial local (autocrine) and systemic (endocrine) mediator in CHF.
  • Further research is essential to fully elucidate CNP's pathophysiological significance in chronic heart failure.